Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

NCT06724237 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
294
Enrollment
NETWORK
Sponsor class

Conditions

Interventions

Sponsor

Eastern Cooperative Oncology Group

Collaborators